Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
TNF-related apoptosis-inducing ligand mediates tumoricidal activity of human monocytes stimulated by Newcastle disease virus
A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer
Dendritic cell therapy of cancer: can it fulfill its promise?
Intradermal injection of Newcastle disease virus-modified autologous melanoma cell lysate and interleukin-2 for adjuvant treatment of melanoma patients with resectable stage III disease
Fusions of breast cancer and dendritic cells as a novel cancer vaccine
HER2 dendritic cell vaccines
Dendritic cell vaccination and viral infection–animal models
The first 1000 dendritic cell vaccinees
Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine
Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients: bidirectional cell stimulation, survival and antitumor activity in vivo
Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer
Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer
Ifosfamide with regional hyperthermia in soft-tissue sarcomas
A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma
Editorial von Prof. Dr. Volker Schirrmacher zum Beitrag „Immuntherapeutische Strategien zur Behandlung solider Tumoren“
Advances in dendritic cell-based vaccine of cancer
Cancer immunotherapy: stress proteins and hyperthermia
Calcitonin-specific antitumor immunity in medullary thyroid carcinoma following dendritic cell vaccination
Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B – restoration by exogenous interleukin-12
Dendritic cells in vaccination therapies of malignant diseases